Summary. The endogenous concentrations of three PGs in the vas deferens of rabbits and rats were low (5\p=n-\50ng/100 mg tissue), although PGE-2 and PGF-2\g=a\were present in greater quantities than 6-keto-PGF-1\g=a\. Homogenates of rat and rabbit vas deferens synthesized these three PGs in large quantities during a 90 min incubation period. PGE-2 was the major PG synthesized by the rat vas deferens, followed by PGF-2\g=a\and 6-keto-PGF-1\g=a\.PG production by the rabbit vas deferens was lower than in the rat and PGF-2\g=a\was the major PG formed.
Introduction
Prostaglandins (PGs) are present in high concentrations (10-1000 µg/ml) in the semen of primates, sheep and goats (Eliasson, 1959;  Kelly, 1978) . The source of these PGs is the seminal vesicles. Prostaglandin (PG) concentrations in the semen of most laboratory animals are low in comparison with those of primates (Eliasson, 1959; Horton & Thompson, 1964; De Cuminsky & Mercuri, 1971 ; Poyser, 1974) . However, the content of PG-like substances in rat and mouse semen, assayed in terms of PGE-1, increases during mating to 1-2 µg per rat and 0-5-1 µg per mouse (Marley & Smith, 1974a) and the source of these PGs is the vas deferens (Marley & Smith, 1974b . Rabbit semen also contains PGE-2 (70 ng/ml) and PGF-2a (30 ng/ml) (Poyser, 1974) , but their source is not known. The endogenous concentrations of PGs in vas deferens tissue of the mouse and rat are higher than in other tissues in the reproductive tract (Badr, Barcikowski & Bartke, 1975; Gerozissis & Dray, 1980) and it has been suggested that PGs produced by the vas deferens are involved in the regulation of sperm transport through this tissue (Badr et al., 1975) . reported to potentiate responses of the vas deferens to noradrenaline in the guinea-pig (von Euler & Hedqvist, 1969; Ambache & Zar, 1970; Euler, 1972) , rat and rabbit (Hedqvist & von Euler, 1972) . However, Bhagat, Dhalla, Ginn, La Montagne & Montier (1970) found that PGE-2 inhibited the responses to noradrenaline in the guinea-pig and Clegg (1966) reported that PGE-1 and PGF-2a both attenuated the responses of the rat vas deferens. The reasons for these discrepancies are not clear.
We have measured tissue levels of, and synthesizing capacity for, 6-keto-PGF-la (reflecting PGI-2 synthesis), PGE-2 and PGF-2a in the vas deferens of the rat and rabbit and examined the direct effects of various PGs and PG analogues on the tone of the rabbit and rat vas deferens.
Materials and Methods
Fully adult New Zealand White rabbits weighing 2-5-3 The other vas deferens was removed, weighed and homogenized in Krebs' solution (119 mMNaCl, 25 mM-NaHC03, 4-7 mM-KCl, 1-2 mM-KH2P04, 2-5 mM-CaCl2, 1-0 mM-MgS04 and 11-1 mM-D-glucose), using 10 ml and 15 ml for tissue from rats and rabbits respectively, and incubated for 90 min at 37°C, gassed with 95% 02, 5% C02. The pH of the incubate was then lowered to pH 4 with 1 N-NC1 and the PGs extracted and stored as above, except that 30 ml ethyl acetate were used for extracting the rabbit incubates. The amounts of PGE-2, PGF-2a and 6-keto-PGF-la formed were measured by RIA. Control experiments in this laboratory have shown that the recovery of PGE-2 and PGF-2a is greater than 90% (Poyser & Scott, 1980) and the recovery of 6-keto-PGF-la is 81-5 ± 2-01% from aqueous media by the methods used. None of the results obtained were corrected for recovery. Experiment 2. Rabbit and rat vasa deferentia were mounted individually in a 10 ml organ bath containing Krebs' solution at 37°C, gassed with 95% 02, 5% C02, under 0-5 g tension. Contractions were recorded isometrically via a Grass FT03 C force displacement transducer coupled to a Servoscribe pen recorder. Tissues were allowed to equilibrate for 30 min before the addition of drugs. In the first series of experiments, the effects of PGE-1, PGE-2, PGD-2, PGF-2a, analogues, ICI 79939 and ICI 81008 (fluprostenol) , and the TXA-2 mimics 9,11-epoxymethano PGH-2 and 11,9-epoxymethano PGH-2, on the resting tone of the rabbit and rat vas deferens were examined. In a second series of experiments, the effects of PGS on the responses elicited by noradrenaline were examined. In the initial experiments, it was observed that several of the PGs potentiated the response of the rabbit and rat vas deferens to noradrenaline when the PG was added 30 sec before or after noradrenaline, although potentiation was greater when the PG was added afterwards. In the main experiments of this series, a log dose-response curve for noradrenaline was obtained on each tissue. Each dose was applied for 5 min and there were 10-min intervals between doses of noradrenaline. The effects of the various PGs on the log dose-response curve were estimated by adding the same doses of noradrenaline to the organ bath, followed 30 sec later by the selected PG. The doses of the different PGs chosen were those that produced similar shifts in the log dose-response curve for noradrenaline so that the relative potencies of the PGs could be compared. In this experiment and in Exp. 3, regression lines were drawn through the appropriate points by computer to obtain the log dose-response relationship. In this experiment, the effect of adding phentolamine (10~7 m) 1 min before the addition of noradrenaline was also examined. (Dighe, Emslie, Henderson, Rutherford & Simon, 1975 ). This antibody cross-reacts with PGF-la (100%), but has low cross-reactivity with other PGs and their metabolites (Poyser & Scott, 1980) . The limit of detection was 25 pg/tube. PGE-2 was measured by an antibody raised in rabbits, which cross-reacts with PGE-1 (100%), PGA-2 (13-6%) and PGB-2 (260%) but has low cross-reactivities with other PGs and their metabolites (Lytton & Poyser, 1982a) . The limit of detection was 25 pg/tube. 6-Keto-PGF-la was measured by an antibody which has low cross-reactivity with other PGs and PG metabolites (Poyser & Scott, 1980) . The detection limit was 25 pg/tube. The intra-assay coefficients of variation, calculated from the variation between duplicate results, were 8-6% (PGF-2a), 9-2% (PGE-2), and 8-2% (6-keto-PGF-la). The interassay coefficients of variation, calculated from the results obtained by incorporating a known amount of each compound into the appropriate assay, were 12-3% (PGF-2a), 4-1% (PGE-2) and 10-9% (6-keto-PGF-la).
Identification of PGs by gas chromatography-mass spectrometry (GC-MS) After being assayed, the extracts of one tissue type were combined to provide two samples. The samples were purified further and then subjected to analysis by GC-MS as described by Poyser (1983 Analysis by GC-MS showed that PGF-2a, PGE-2 and 6-keto-PGF-la were present in extracts from rat vas deferens. PGE-1, PGA-2, PGB-2 and PGF-la were not detected in these extracts.
Unfortunately, the mass spectra of the rabbit extracts taken at the retention times of the authentic PGs contained too many m/e peaks for the m/e peaks due to any PG present to show clearly above the background 'biological noise'. Consequently, in spite of the extra purification step, the extracts of rabbit vas deferens still contained much higher levels of impurities than did the extracts of the rat vas deferens, thus making the GC-MS analysis of the rabbit extracts inconclusive. However, the PGE-2 antiserum was more likely to be measuring PGE-2 than PGB-2 since a biochemical pathway for the conversion of PGE-2 into PGB-2 has not been reported. The rabbit vas deferens produced significantly more (P < 0-01) PGF-2a than PGE-2 or 6-keto-PGF-la. PGE-2 and 6-keto-PGF-la production did not differ significantly (Text- fig. 1 ). The rat vas deferens produced significantly more (P < 0-01) PGE-2 than 6-keto-PGF-la. PGF-2a production did not differ significantly from PGE-2 or 6-keto-PGF-la production (Text- fig. 1 ).
Experiment 2
Neither the rabbit nor rat vas deferens responded directly to any of the prostanoids tested, i.e. PGE-1, PGD-2, PGI-2 in concentrations of up to 1 µ^/ , PGE-2 and PGF-2a up to 20 µg/ml, 9,11-epoxymethano PGH-2, 11,9-epoxymethano PGH-2, ICI 79939 and ICI 81008 up to 10 µg/ml.
The rabbit vas deferens responded to noradrenaline by producing rhythmic contractions. Functional activity was assessed by summing the increase in tension produced by each contraction during a 5-min period after adding noradrenaline. The relationship between functional activity and log [noradrenaline] was linear for the dose range 1-10 µg noradrenaline/ml (correlation coefficient, r = 0-97). Noradrenaline (1-10 µg/ml) -induced contractions were abolished by phentolamine (10~7 m), showing that the noradrenaline was acting on a-adrenoreceptors. Due to tachyphylaxis, it was difficult to determine the maximum response to noradrenaline. Text- figure 2 shows that in the (b) (c) The rat vas deferens responded to noradrenaline by a sustained increase in tone. PGE-1, PGE-2, PGI-2 and PGF-2a in concentrations of up to 400 ng/ml usually did not affect the response although occasionally potentiation or inhibition (10-15%) was seen. The substances 9,11-epoxymethano PGH-2, 11,9-epoxymethano PGH-2, ICI 79939 and ICI 81008 in concentrations of up to 10 µ §/ 1 or PGD-2 (1 µg/ml) did not affect responses of the rabbit and rat vas deferens to noradrenaline.
Experiment 3 PGE-1 (80 ng/ml) and PGE-2 (100 ng/ml) reduced the contractions of the rabbit vas deferens due to field stimulation. PGI-2 also reduced the responses but the dose required was far greater (600 ng/ml). When the response, expressed as a % ofthat before the addition of PG, was plotted against the log dose of PG added (Text- fig. 3 ) PGE-1 and PGE-2 were equipotent whereas PGI-2 was far less potent. Even with 10 µg PGI-2/ml, no more than 60% inhibition was obtained, compared with 80% inhibition produced by PGE-2 and PGE-1 at much lower concentrations (400 ng/ml).
PGD-2, PGF-2a in concentrations of up to 1 µg/ml, 9,11-epoxymethano PGH-2, 11,9-epoxymethano PGH-2, ICI 79939 and ICI 81008 in concentrations of up to 10 µg/ml had no effect on the field-stimulated rabbit vas deferens.
The rat vas deferens was far less sensitive to PGs, and only 20% inhibition of responses to field stimulation was seen with doses of 400 ng PGE-1 or PGE-2/ml. Further increases of the dose produced no further inhibition. No other prostanoid, i.e. PGD-2, PGF-2a, PGI-2 in concentrations of up to 1 µg/ml, 9,11-epoxymethano PGH-2,11,9-epoxymethano PGH-2, ICI 79939 and ICI 81008 in concentrations of up to 10 µ §/ 1, had any effect on the field-stimulated rat vas deferens. (Poyser, 1972) (Poyser & Scott, 1980; Lytton & Poyser, 1982b) . The major PG synthesized by the rat vas deferens was PGE-2, while the major PG synthesized by the rabbit vas deferens was PGF-2a. However, the rabbit vas deferens contained slightly more PGF-2a than PGE-2, while this ratio was reversed in the rat vas deferens. Since both the rat and rabbit vas deferens contained considerably more PGF-2a and PGE-2 than 6-keto-PGF-la, and if endogenous concentrations reflect PG synthesis in vivo, then the intact vas deferens of the rabbit and rat synthesize PGF-2a and PGE-2 in preference to 6-keto-PGF-la.
Although the vas deferens of the rabbit and rat can synthesize PGs, we have failed to see any direct effect of PGs or PG analogues on the smooth muscle of this tissue in vitro. PGI-2 was more potent than PGE-2 or PGF-2a in potentiating responses to noradrenaline in the rabbit vas deferens. PGD-2, 9,11-epoxymethano PGH-2, 11,9-epoxymethano PGH-2, ICI 79939 and ICI 81008 were ineffective. Although both inhibition and potentiation were occasionally observed, no consistent effect of PGs on responses of the rat vas deferens to noradrenaline was seen.
PGE-1, PGE-2 and PGI-2 inhibited the response of the rabbit vas deferens to field stimulation, with PGE-1 and PGE-2 being equipotent and PGI-2 being far less potent. Hedqvist & von Euler (1972) found that PGE-1 and PGE-2 inhibit the response to field stimulation in cat, rat, guinea-pig and rabbit vasa deferentia, while PGF-2a only caused slight inhibition. The rat vas deferens was far less sensitive to PGE-1 and PGE-2, as found by Hedqvist & von Euler (1972) . PGI-2 had no effect on contractions of the rat vas deferens produced by field stimulation while PGE-1 and PGE-2 produced only a weak inhibitory effect.
In several of our studies on the field-stimulated rat and rabbit vas deferens, phentolamine (7 IO-6 m, an -adrenoreceptor antagonist) and bretylium (10~s M, an inhibitor of noradrenaline release from nerve endings) were added to the organ bath at the end of the study (which usually lasted 2-4 h). These inhibitors greatly reduced (>90%) the responses of the tissue to field stimulation, suggesting that the responses were due predominantly to stimulation of adrenergic nerves. Since PGE-2 inhibits release of noradrenaline from several tissues, including the transmurally stimulated guinea-pig vas deferens (Hedqvist, 1974) , it would appear that PGE-2 and PGE-1 caused reduction in the response of the field-stimulated rat and rabbit vas deferens by inhibiting noradrenaline output from the sympathetic nerves. (PGI-2 had a similar effect on the rabbit vas deferens but it was much less potent than PGE-1 or PGE-2.) However, the rat vas deferens has adrenergic and non-adrenergic components in the response elicited by field stimula¬ tion; these are best seen by using single electrical pulses rather than a train of pulses (McGrath, 1978) . The 'non-adrenergic transmitter' is not known. PGE-2 reduces contractions of the rat vas deferens elicited by stimulation of the non-adrenergic component, but has no effect on or, in higher concentrations, ability to potentiate the contractions of the rat vas deferens elicited by the adrenergic component (Bedwani & Blanning, 1983) . Since in the present study, contractions of the rat vas deferens sustained over a 5-sec period were apparently due largely to stimulation of the adrenergic component (by using a train of stimuli), the lack of effect of PGE-2 and PGE-1 on noradrenaline release in the rat vas deferens may be the reason why PGE-2 and PGE-1 had only a weak inhibitory effect on the contractions elicited by field stimulation in our investigations. This inhibitory effect of PGE-2 and PGE-1 may have been due to inhibition of release of the nonadrenergic transmitter. Neither PGI-2 nor any of the other prostanoids tested apparently has this inhibitory action on the release of the non-adrenergic transmitter in the rat vas deferens.
The rabbit vas deferens also appears to have a non-adrenergic component to its contraction elicited by field stimulation (Adebanjo & Ambache, 1978) . However, these components in the rabbit vas deferens are not so well characterized as in the rat vas deferens. Since PGE-2 and PGE-1 had a much greater effect on the rabbit than on the rat vas deferens in reducing contractions elicited by field stimulation using a train of pulses (the sustained contractions appearing to be predominantly adrenergic in nature), PGE-2, PGE-1 and PGI-2 were probably reducing the contractions by inhibiting noradrenaline release from the adrenergic nerves, as reported for the guinea-pig vas deferens (Hedqvist, 1974) . However, the effects of PGs on transmitter release in the rabbit vas deferens merit further study.
The nature of the receptors involved in the responses to PGs on the rat and rabbit vas deferens is not known. However, SC 19920, an inhibitor of PGE-2 action on the guinea-pig ileum (Sanner, 1969) , inhibits the post-junctional potentiating effects of PGE-1 elicited by noradrenaline on the guinea-pig vas deferens without affecting the pre-junctional inhibitory effects of PGE-1 on contractions elicited by field stimulation. This would indicate that pre-and post-junctional PG receptors are different. This is supported by the present findings that PGI-2 is the most potent postjunctionally while PGE-2 and PGE-1 are the most potent pre-junctionally at producing the appropriate effects, assuming that the PG-mediated events are mediated by single PG receptors at each site. PGF-2a potentiated the contractions of the rabbit vas deferens elicited by noradrenaline (and was approximately equipotent with PGE-2), but neither of the luteolytic PGF-2a analogues (ICI 79939 and ICI 81008) had this effect, indicating that the receptors with which PGF-2a combines on the corpus luteum and the vas deferens are different. Also, neither of the prostanoids with potent TXA-2 activity nor PGD-2 had any pre-or post-junctional effects on the rabbit or rat vas deferens, suggesting that TXA-2 and PDG-2 are without effect on the contractile activity of this tissue.
The physiological significance of the pre-and post-junctional actions of PGs on the vas deferens is unknown at present. Tomlinson (1980) Hafs, Louis & Stellflug (1974) found that injection of PGF2a around the testis and epididymis of the rabbit doubles the number of spermatozoa in the vas deferens when compared to controls. In another study, administration of PGF-2a to rabbits tripled sperm numbers in the vas deferens and doubled sperm output, although treatment with PGF-2a and PGE-2 daily for 60 days failed to alter sperm production or fertility (Reichard et al., 1978) . PGs can therefore affect sperm transport but as yet there appear to be no reports of the action of PGI-2 on sperm transport. This study was supported by a grant from the M.R.C.
